HMGI-C, also known as High Mobility Group AT-Hook 2 (HMGA2), stands as a key architectural transcription factor involved in the regulation of gene expression and chromatin structure. Functionally, HMGI-C exerts its effects by binding to AT-rich DNA sequences through its AT-hook domains, thereby modulating the chromatin architecture and facilitating the assembly of transcriptional regulatory complexes. HMGI-C primarily functions as a transcriptional activator, promoting gene expression by enhancing the accessibility of target genes to transcription factors and RNA polymerase machinery. Through its interactions with various transcriptional regulators and chromatin-modifying enzymes, HMGI-C plays a crucial role in diverse cellular processes, including embryonic development, cell proliferation, differentiation, and oncogenesis.
Activation of HMGI-C is governed by intricate regulatory mechanisms operating at both the transcriptional and post-translational levels. Transcriptional activation of HMGI-C gene expression is orchestrated by a myriad of signaling pathways and transcription factors responsive to extracellular cues, developmental signals, and environmental stimuli. Notably, growth factors, hormones, and inflammatory mediators activate HMGI-C expression by stimulating the transcriptional activity of specific transcription factors, such as Sp1, AP-1, and NF-κB, which bind to the HMGI-C promoter region and initiate gene transcription. Furthermore, post-translational modifications, including phosphorylation, acetylation, and methylation, regulate HMGI-C activity and stability, influencing its subcellular localization, DNA-binding affinity, and interaction with cofactors. The dynamic interplay between transcriptional and post-translational mechanisms ensures tight control over HMGI-C activation, thereby modulating its diverse functions in gene regulation and cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates retinoic acid receptors (RARs) which can upregulate HMGI-C expression as part of gene transcription modulation in cell differentiation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can lead to the demethylation and consequent activation of HMGI-C gene expression in certain cell types. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic acid is an inhibitor of histone acetyltransferase, which can lead to altered gene expression patterns including upregulation of HMGI-C. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can activate pathways that lead to increased expression of HMGI-C as a stress response, modulating cellular proliferation and survival. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP acts as a cAMP analog, activating PKA, which can lead to changes in transcriptional regulation including upregulation of HMGI-C. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $38.00 $48.00 | ||
Kinetin can influence gene expression and might enhance the expression of HMGI-C through its role in cell growth and differentiation. | ||||||
Pioglitazone hydrochloride | 112529-15-4 | sc-204848 sc-204848A | 100 mg 500 mg | $63.00 $213.00 | 19 | |
Pioglitazone engages peroxisome proliferator-activated receptor gamma (PPARγ), potentially increasing HMGI-C expression linked to adipocyte differentiation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can activate NRF2, leading to the transcriptional activation of various genes, potentially including those involved in HMGI-C mediated pathways. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, a phosphodiesterase inhibitor, can raise intracellular cAMP levels, which may result in transcriptional changes including the activation of HMGI-C. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
3′-Azido-3′-deoxythymidine is known to influence cellular DNA synthesis pathways and might upregulate HMGI-C expression as part of its broader effects on nucleotide processing. | ||||||